Paper39136000
Interaction of the intestinal cytokines-JAKs-STAT3 and 5 axes with RNA N6-methyladenosine to promote chronic inflammation-induced colorectal cancer.
Esmaeili N and 4 others. Front Oncol, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Interaction of the intestinal cytokines-JAKs-STAT3 and 5 axes with RNA N6-methyladenosine to promote chronic inflammation-induced colorectal cancer. Papers, record 39136000. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39136000
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Interaction of the intestinal cytokines-JAKs-STAT3 and 5 axes with RNA N6-methyladenosine to promote chronic inflammation-induced colorectal cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 DK123299 | NIDDK NIH HHS | United States | R01DK123299 | PubMed and NIH |
Source NIH RePORTER
References163
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 2 | 34122629 | LINC00857 promotes cell proliferation and migration in colorectal cancer by interacting with YTHDC1 and stabilizing SLC7A5. | Oncol Lett | 2021 | https://conductscience.org/library/papers/34122629 | PubMed |
| 3 | 32606006 | FTO-Dependent N 6-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling. | Cancer Res | 2020 | https://conductscience.org/library/papers/32606006 | PubMed |
| 4 | 34490250 | Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34490250 | PubMed |
| 5 | 33947841 | Circular RNA hsa_circ_0006401 promotes proliferation and metastasis in colorectal carcinoma. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33947841 | PubMed |
| 6 | 7722410 | A direct signaling pathway through tyrosine kinase activation of SH2 domain-containing transcription factors. | J Leukoc Biol | 1995 | https://conductscience.org/library/papers/7722410 | PubMed |
| 7 | 25773877 | Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma. | Ann Surg Oncol | 2015 | https://conductscience.org/library/papers/25773877 | PubMed |
| 8 | 16192273 | Structure of the unphosphorylated STAT5a dimer. | J Biol Chem | 2005 | https://conductscience.org/library/papers/16192273 | PubMed |
| 9 | 26312921 | Effect of methotrexate on JAK/STAT pathway activation in myeloproliferative neoplasms. | Lancet | 2015 | https://conductscience.org/library/papers/26312921 | PubMed |
| 10 | 2236065 | ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2236065 | PubMed |
| 11 | 33335958 | Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology. | Genes Dis | 2020 | https://conductscience.org/library/papers/33335958 | PubMed |
| 12 | 33906563 | M6ADD: a comprehensive database of m6A modifications in diseases. | RNA Biol | 2021 | https://conductscience.org/library/papers/33906563 | PubMed |
| 13 | 36347844 | FMR1 promotes the progression of colorectal cancer cell by stabilizing EGFR mRNA in an m6A-dependent manner. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/36347844 | PubMed |
| 14 | 34347395 | The m6A writers regulated by the IL-6/STAT3 inflammatory pathway facilitate cancer cell stemness in cholangiocarcinoma. | Cancer Biol Med | 2021 | https://conductscience.org/library/papers/34347395 | PubMed |
| 15 | 34974791 | Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance. | Bioengineered | 2022 | https://conductscience.org/library/papers/34974791 | PubMed |
| 16 | 34916487 | TCF4 and HuR mediated-METTL14 suppresses dissemination of colorectal cancer via N6-methyladenosine-dependent silencing of ARRDC4. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34916487 | PubMed |
| 17 | 34149792 | Prognostic Implication of the m6A RNA Methylation Regulators in Rectal Cancer. | Front Genet | 2021 | https://conductscience.org/library/papers/34149792 | PubMed |
| 18 | 30787270 | m6A methylation controls pluripotency of porcine induced pluripotent stem cells by targeting SOCS3/JAK2/STAT3 pathway in a YTHDF1/YTHDF2-orchestrated manner. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/30787270 | PubMed |
| 19 | 33010174 | RMDisease: a database of genetic variants that affect RNA modifications, with implications for epitranscriptome pathogenesis. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/33010174 | PubMed |
| 20 | 32765970 | Role of methyltransferase-like enzyme 3 and methyltransferase-like enzyme 14 in urological cancers. | PeerJ | 2020 | https://conductscience.org/library/papers/32765970 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42908874 | Pulsatilla decoction attenuates colorectal cancer progression in association with gut microbiota remodeling, T-cell immune restoration, and NF-κB/JAK2/STAT3 signaling suppression. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/42908874 | PubMed |
| 41377462 | P4HB regulates tumor-associated macrophage polarization and chemotaxis by enhancing IL-6 cytokine secretion in glioblastoma. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/41377462 | PubMed |
| 40420174 | Targeting inflammation in cancer therapy: from mechanistic insights to emerging therapeutic approaches. | J Transl Med | 2025 | https://conductscience.org/library/papers/40420174 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| STAT3 | 6774 | PubTator's text mining | https://conductscience.org/library/genes/6774 | NCBI Gene |
| STAT5A | 6776 | PubTator's text mining | https://conductscience.org/library/genes/6776 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39136000
GET https://conductscience.org/api/papers/v1/39136000/references?page=2